Significant drop in hepatocellular carcinoma cases reported in 2020 vs. pre-COVID years

CHICAGO — Reported cases of hepatocellular carcinoma decreased significantly in 2020 compared with years before the COVID-19 pandemic, although there was minimal impact on tumor stage and patients receiving curative treatment.“Since the emergence of COVID-19, several studies have shown a substantial alteration in HCC screening and management,” Bhupinder Kaur, MD, a second-year resident at Cedars-Sinai Medical Center in Los Angeles, said at Digestive Disease Week. “However, less is known about the change in magnitude of HCC diagnosis and treatment during the COVID-19Read More